Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

David Portnoy, MD, FACP Previews Immunotherapy Breakthroughs – Shaking Up Frontline SCLC Paradigm

Posted by & filed under Uncategorized.

Click here to view this full article on OncLive.com.    The addition of immune checkpoint inhibitors to chemotherapy has led to durable responses and improved survival without increased toxicity in patients with small cell lung cancer (SCLC), according to David C. Portnoy, MD, FACP, who added that biomarkers of response to this approach and a… Read more »

X